236 related articles for article (PubMed ID: 11120800)
1. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
[TBL] [Abstract][Full Text] [Related]
2. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
[TBL] [Abstract][Full Text] [Related]
3. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL.
McAdam AJ; Gewurz BE; Farkash EA; Sharpe AH
J Immunol; 2000 Sep; 165(6):3088-93. PubMed ID: 10975820
[TBL] [Abstract][Full Text] [Related]
4. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
[TBL] [Abstract][Full Text] [Related]
5. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86.
Agadjanyan MG; Chattergoon MA; Holterman MJ; Monzavi-Karbassi B; Kim JJ; Dentchev T; Wilson D; Ayyavoo V; Montaner LJ; Kieber-Emmons T; Sekaly RP; Weiner DB
J Immunol; 2003 Oct; 171(8):4311-9. PubMed ID: 14530356
[TBL] [Abstract][Full Text] [Related]
6. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.
Cho HJ; Hayashi T; Datta SK; Takabayashi K; Van Uden JH; Horner A; Corr M; Raz E
J Immunol; 2002 May; 168(10):4907-13. PubMed ID: 11994440
[TBL] [Abstract][Full Text] [Related]
7. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
[TBL] [Abstract][Full Text] [Related]
8. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.
Takamura S; Matsuo K; Takebe Y; Yasutomi Y
J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827
[TBL] [Abstract][Full Text] [Related]
9. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL.
Prilliman KR; Lemmens EE; Palioungas G; Wolfe TG; Allison JP; Sharpe AH; Schoenberger SP
J Immunol; 2002 Oct; 169(8):4094-7. PubMed ID: 12370335
[TBL] [Abstract][Full Text] [Related]
11. B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination.
Santra S; Barouch DH; Sharpe AH; Letvin NL
Eur J Immunol; 2000 Sep; 30(9):2650-9. PubMed ID: 11009099
[TBL] [Abstract][Full Text] [Related]
12. Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo.
Seaman MS; Peyerl FW; Jackson SS; Lifton MA; Gorgone DA; Schmitz JE; Letvin NL
J Virol; 2004 Jan; 78(1):206-15. PubMed ID: 14671102
[TBL] [Abstract][Full Text] [Related]
13. Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.
Cusi MG; Del Vecchio MT; Terrosi C; Savellini GG; Di Genova G; La Placa M; Fallarino F; Moser C; Cardone C; Giorgi G; Francini G; Correale P
J Immunol; 2005 Jun; 174(11):7210-6. PubMed ID: 15905566
[TBL] [Abstract][Full Text] [Related]
14. Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.
Kim JJ; Nottingham LK; Wilson DM; Bagarazzi ML; Tsai A; Morrison LD; Javadian A; Chalian AA; Agadjanyan MG; Weiner DB
Vaccine; 1998 Nov; 16(19):1828-35. PubMed ID: 9795388
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K
Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895
[TBL] [Abstract][Full Text] [Related]
16. M cell DNA vaccination for CTL immunity to HIV.
Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
[TBL] [Abstract][Full Text] [Related]
17. Costimulation provided by DNA immunization enhances antitumor immunity.
Corr M; Tighe H; Lee D; Dudler J; Trieu M; Brinson DC; Carson DA
J Immunol; 1997 Nov; 159(10):4999-5004. PubMed ID: 9366427
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
19. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
20. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
